NCT01084655 2019-07-30
Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer
Takeda
Phase 1/2 Completed
Clinical Trials
3 trialsNCT01666314 2018-03-20
Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer
Takeda
Phase 1/2 Completed
NCT00569153 2016-04-04
TAK-700
Millennium Pharmaceuticals, Inc.
Phase 1/2 Completed